Effect on Primary Dysmenorrhea
Public ClinicalTrials.gov record NCT00909857. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Double-blind, Double-dummy, Randomized, Controlled, Parallel-group Study to Assess Efficacy and Safety of SH T00658ID Compared to SH D593B in the Treatment of Primary Dysmenorrhea
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To investigate the potential benefits of a new oral contraceptive (SH T00658ID) on alleviating complaints of dysmenorrhea associated with oral contraceptive use.
Study identification
- NCT ID
- NCT00909857
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 507 participants
Conditions and interventions
Conditions
Interventions
- Estradiol valerate, Dienogest (Natazia, Qlaira, BAY86-5027) Drug
- Ethinyl estradiol, Levonorgestrel (Miranova) Drug
- Placebo Match to SH T00658ID Drug
- Placebo Match to SH D593B Drug
Drug
Eligibility (public fields only)
- Age range
- 14 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2009 (Type not available)
- Primary completion
- Nov 2010 (Actual)
- Completion
- Nov 2010 (Actual)
- Last update posted
- Aug 24, 2015
2009 – 2010
United States locations
- U.S. sites
- 10
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Tucson | Arizona | 85741 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | Hialeah | Florida | 33012 | — |
| Not listed | Leesburg | Florida | 34748 | — |
| Not listed | Sandy Springs | Georgia | 30328 | — |
| Not listed | Idaho Falls | Idaho | 83404 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Philadelphia | Pennsylvania | 19114 | — |
| Not listed | Pittsburgh | Pennsylvania | 15206 | — |
| Not listed | La Crosse | Wisconsin | 54691 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00909857, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 24, 2015 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00909857 live on ClinicalTrials.gov.